The drug information sheets that the FDA requires companies to produce are living documents that get updated with new ...
Unraveling mechanisms underlying post-acute SARS-CoV-2 sequelae (long COVID) and finding therapeutic solutions require a full understanding of the causative role of SARS-CoV-2 persistence and/or ...
Federal judges signaled a willingness Monday to overrule a lower-court judge who rejected cases lodged by families claiming ...
Gilead Sciences, Inc. today announced the delivery of first shipments of lenacapavir ? Gilead's twice-yearly injectable HIV-1 capsid inhibitor ? for the prevention of HIV as pre-exposure prophylaxis ...
Experts today sounded an alarm over the death toll as millions more are in line to get the jabs to curb the nation's bulging ...
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, ...
Sorfequiline, previously known as TBAJ-876, was evaluated in combination with pretomanid and linezolid in a randomized, controlled trial in people with drug-sensitive TB COPENHAGEN (November 19, 2025) ...
Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...
News-Medical.Net on MSN
New clinical trial shows promise for shorter TB treatment
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
My primary care doctor has prescribed the medication Evenity for my osteoporosis. I have been on Fosamax for about three years, but my recent bone density scan ...
We show that, compared with surgeon predictions and existing risk-prediction tools, our machine-learning model can enhance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback